(5) Now in Dec 2017 OMHE announced its plan already in motion to create a drug candidate compelling to Big Pharma, development of cannabidiol pain treatment therapeutic & medicine and filing of FDA registration by employing an FDA regulations-savvy, ‘fast-track’ pipeline strategy. CLICK HERE TO READ DEC 2017 FDA REGISTRATION UPDATE
OMHE PPS Ready to Rise to $1
Made Thousands into Millions..Now in Tens of Millions
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.